Noble Financial Downgrades Protalix BioTherapeutics (PLX) to Hold; Taliglucerase Alfa Receives Complete Response Letter

February 25, 2011 10:27 AM EST Send to a Friend
Noble Financial downgraded Protalix BioTherapeutics (NYSE: PLX) to Hold.

Noble analyst says, "On February 25, 2011, Protalix received notice that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login